Roche Pharmaceuticals signs 3 Memoranda of Understanding that strengthen its role as a partner in supporting healthcare transformation
Roche Pharmaceuticals in Saudi Arabia, one of the world’s leading healthcare companies, signed three Memoranda of Understanding with the Saudi Health Council, Riyadh Health Cluster 1, and Makkah Health Cluster, as part of partnerships aimed at supporting the health transformation in the Kingdom and enhancing integration between the public and private sectors, which contributes to improving the quality of health services and enhancing the beneficiary experience at the system level.
These agreements reflect a long-term partnership approach with national entities, through the development of sustainable cooperation models that focus on prevention, capacity building, and the use of health innovation, in line with the objectives of Saudi Vision 2030, and enhance the efficiency and sustainability of the health system in the long term. 
Dr. Abdulrahman Sabra, General Manager of Roche Pharmaceuticals in Saudi Arabia, said: “These partnerships reflect our firm commitment to supporting the health transformation path in the Kingdom, in line with the objectives of Saudi Vision 2030. They also come as an extension of the partnerships we signed during the past year with the Ministry of Health and a number of national entities, which consolidates a sustainable approach at the level of the health system to accelerate the adoption of digital health solutions, enhance prevention, and improve the patient experience and quality of health care in various regions of the Kingdom.”. 
The memorandum of understanding signed with the Saudi Health Council focuses on supporting national efforts related to eye health resulting from diabetes, through a cooperation framework that promotes awareness, encourages screening and early detection, and supports capacity building for health practitioners, in addition to joint work towards developing national policies that contribute to improving preventive and clinical practices and measuring their impact systematically and effectively.
The memorandum of understanding with the First Riyadh Health Cluster also includes areas of cooperation aimed at promoting scientific research and clinical studies through advanced technological solutions, improving specialized services, enhancing the beneficiaries’ experience, in addition to exchanging experiences and building capacities.
Finally, the memorandum of understanding with the Makkah Health Cluster focuses on employing health innovation and private sector expertise to support the quality and efficiency of healthcare in one of the most diverse health environments in terms of the volume of services and the number of beneficiaries.
The partnership with the Makkah Health Cluster is based on three main pillars, including building pharmacoeconomic capabilities, enhancing screening and early detection programs, and improving the beneficiary journey and its outcomes through effective health solutions programs and digital health applications.
